Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: A controlled pilot study

Journal of Hepatology

Volumn 36, Issue 6, 2002, Pages 799-804

  Santantonio, Teresa ^a   Anna Niro, Grazia ^b   Sinisi, Emanuele ^a   Leandro, Gioacchino ^c   Insalata, Maria ^a   Guastadisegni, Angela ^a   Facciorusso, Domenico ^b   Gravinese, Eleonora ^b   Andriulli, Angelo ^b   Pastore, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c Istituto di Ricovero e Cura A Carattere Scientifico S de Bellis   (Italy)

Author keywords

Anti HBe positive chronic hepatitis B; Antiviral therapy; Combination therapy; Drug resistance; Interferon; Lamivudine; YMDD mutants

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEPATITIS B(E) ANTIBODY; LAMIVUDINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC CODE; HEPATITIS B; HUMAN; MALE; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MOTIF; SEQUENCE ANALYSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERONS; LAMIVUDINE; MALE; MIDDLE AGED; PILOT PROJECTS; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME;

EID: 0036623206     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00056-9     Document Type: Article

References (24)

1. Lai CL, Chien RN, Leung NWY, Chang TT, Guan R, Tai DI, et al. A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-68.
2. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HWL, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-1263.
3. Lau DTY, Khokhar F, Doo E, Ghany MG, Herion D, Park Y, et al. Long-term term therapy of chronic hepatitis B with lamivudine. Hepatology 2000;32:828-834.
4. Santantonio T, Mazzola M, Iacovazzi T, Miglietta A, Guastadisegni A, Pastore G. Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. J Hepatol 2000;32:300-306.
5. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Hepatology 1999;29:889-896.
6. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Gray DF, et al. Post lamivudine treatment follow-up of patients with HBeAg negative chronic hepatitis B [abstract]. J Hepatol 1999; 30(Suppl 1):N.P/C06/015.
7. Oliveri F, Santantonio T, Bellati G, Colombatto P, Colloredo Mels G, Carriero L, et al. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol 1999;94:1366-1372.
8. Zeuzem S, de Man RA, Honkoop P, Roth WK, Schalm SW, Schmidt JM. Dynamics of hepatitis B virus infection in vivo. J Hepatol 1997;27:431-436.
9. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996;93:4398-4402.
10. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DLJ, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology 1998;27:1670-1677.
11. Si Ahmed SN, Tavan D, Pichoud C, Berby F, Stuyver L, Johnson M, et al. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B. Hepatology 2000;32:1078-1088.
12. Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999;30:567-572.
13. Hadziyannis SJ, Papatheodoridis GV, Dimou E, Laras A, Papaioannou C. Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2000;32:847-851.
14. Santantonio T, Sinisi E, Mazzola M, Insalata M, Guastadisegni A, Pastore G. Long-term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis. J Hepatol 2001;34(Suppl. 1):134 (abs 114).
15. Liaw Y-F, Leung NWY, Chang T-T, Guan R, Tai D-I, Ng K-Y, et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology 2000;119:172-180.
16. Schalm SW, Weiland O, Hansen BE, Milella M, Lai MY, Hollander A, et al. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Gastroenterology 1999;117:408-413.
17. Locarnini S, Birch C. Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients. J Hepatol 2000;30:536-550.
18. Chayama K, Suzuki Y, Kobayashi M, Kobayashi M, Tsubota A, Hashimoto M, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 1998;27:1711-1716.
19. Tatulli I, Francavilla R, Rizzo GL, Vinciguerra V, Ierardi E, Amoruso A, et al. Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B. J Hepatol 2001;35(6):805-810.
20. Jaboli MF, Roda E, Fabbri C, Marchetto S, Azzaroli F, Mazzella G. The efficacy and safety of long-term administration of alpha-IFN and lamivudine in patients with chronic hepatitis B [abstract]. Digest Liver Dis 2001;33:A24.
21. Schalm SW, Heathcote J, Cianciara J, Farrell G, Sherman M, Willems B, et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut 2000;46:562-568.
22. Rang A, Günter S, Will H. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J Hepatol 1999;31:791-799.
23. Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998;102:968-975.
24. Korba BE. In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res 1995;29:49-51.